Warning: Undefined variable $page_cluster_id in /home3/thegood9/public_html/website_70aad9ea/header.php on line 29



Warning: Undefined variable $target_date in /home3/thegood9/public_html/website_70aad9ea/tag.php on line 61

Warning: Undefined variable $target_date in /home3/thegood9/public_html/website_70aad9ea/tag.php on line 77

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Tag Directory / GOVERNMENTPOLICY     showing 181–199 of 199   RSS



Warning: Undefined variable $target_date in /home3/thegood9/public_html/website_70aad9ea/tag.php on line 161

AHA President Rick Pollack to retire by end of 2026

fiercehealthcare - Longtime American Hospital Association President Rick Pollack will retire by the end of 2026, the organization announced on Wednesday.

AI Summary: Longtime American Hospital Association President Rick Pollack is set to retire by the end of 2026, signaling a major leadership transition in U.S. hospital lobbying. Reports note his decades‐long influence and spark speculation about the AHA’s next era of strategic direction.

#healthcare #publichealth #governmentpolicy

5 months / fiercehealthcare


Back to Top / Wednesday, December 10, 2025, 6:23 pm / permalink 16812 / 3 stories in 5 months /

ACA approval hits new high as subsidies set to expire: 7 things to know

Alan Condon / beckershospitalreview - Approval of the ACA recently climbed to a new high of 57% — driven largely by a surge in support among independents — even as pandemic‑era enhanced subsidies are set to expire Dec. 31 unless Congress acts, according to a survey published Dec. 8 by the Wes…

AI Summary: Multiple reports point to growing concerns that the impending expiration of expanded Affordable Care Act subsidies could leave millions facing steep premium hikes or loss of coverage. Survey findings and policy analyses underscore the potential financial strain on vulnerable populations as the deadline nears.

#healthcare #drugpricing #publichealth #governmentpolicy

5 months / medicalxpress

5 months / medicalxpress

5 months / oncodaily

5 months / medicalxpress

5 months / medicalxpress

5 months / medicalxpress

5 months / fiercehealthcare

5 months / medicalxpress

5 months / npr / Hosts


Back to Top / Monday, December 8, 2025, 12:22 pm / permalink 16702 / 21 stories in 5 months /

Will All Newborns Still Receive Hepatitis B Shots? A Committee’s Vote Will Tell.

Apoorva Mandavilli / nytimes - The federal vaccine panel appointed by Health Secretary Robert F. Kennedy Jr. is likely to decide on Thursday that the shots should be delayed for infants whose mothers test negative for the virus.

AI Summary: Multiple posts detail a contentious re‐evaluation of the newborn hepatitis B vaccination schedule. As a federal committee prepares for a key vote, figures such as RFK Jr. warn that delaying routine vaccination may leave infants less protected, sparking heated debate across the healthcare community.

#healthcare #publichealth #governmentpolicy #cdc #vaccinesafety

5 months / medicalxpress

5 months / npr / Andrea Hsu


Back to Top / Sunday, December 7, 2025, 10:22 am / permalink 16672 / 6 stories in 5 months /

California Discourages Wild Mushroom Foraging After Fatal Outbreak

Hannah Ziegler / nytimes - Officials said one person was killed and 20 others were poisoned after eating death cap mushrooms, which look and taste like safe mushrooms but can cause liver failure.

AI Summary: California health officials report that a deadly outbreak—killing one person and poisoning 20 others after death cap mushrooms were mistaken for edible varieties—has forced officials to warn the public against wild mushroom foraging. The state identified 21 poisoning cases, leaving foragers with a grim reminder to stick to their grocery store mushrooms.

#healthcare #publichealth #governmentpolicy

5 months / medicalxpress

5 months / go


Back to Top / Saturday, December 6, 2025, 8:21 pm / permalink 16668 / 3 stories in 5 months /

ACIP drops universal hepatitis B birth dose recommendation

Max Bayer / endpoints - A panel of CDC vaccine advisors has stopped recommending that all children receive the hepatitis B vaccine at birth, overruling scientific consensus and public health officials who pleaded that there was no grounded rationale for ...

AI Summary: A panel of CDC vaccine advisors has upended decades‑old practice by halting the universal administration of hepatitis B vaccine at birth. Citing evolving scientific evidence, the change aims to more precisely target high‑risk infants and re‐calibrate newborn immunization protocols, representing a significant policy pivot in pediatric healthcare.

#healthcare #publichealth #governmentpolicy #cdc #vaccinesafety

5 months / medicalxpress

5 months / medicalxpress

5 months / fiercehealthcare

5 months / medicalxpress

5 months / medicalxpress

5 months / medicalxpress

5 months / livescience


Back to Top / Friday, December 5, 2025, 11:22 am / permalink 16612 / 14 stories in 5 months /

A dozen former FDA commissioners blast Prasad's proposed vaccine policy changes

fiercehealthcare - Drastic overhauls of U.S. vaccine regulations proposed by top FDA official Vinay Prasad, M.D., have drawn harsh pushback from 12 former commissioners of the agency.

AI Summary: A dozen former FDA commissioners have fiercely criticized the proposed overhaul of U.S. vaccine regulations spearheaded by FDA official Vinay Prasad, warning it could undermine decades‐old safety standards and erode public trust in immunization.

#healthcare #publichealth #governmentpolicy #biotech #drugdevelopment #fda #vaccinesafety

5 months / fiercehealthcare

5 months / medicalxpress

5 months / medicalxpress

5 months / fiercehealthcare


Back to Top / Thursday, December 4, 2025, 10:23 am / permalink 16565 / 10 stories in 5 months /

UK and US agree zero-tariff deal on pharmaceuticals

go - Officials say the U.K. has sealed a deal securing a 0% tariff rate for all U.K. medicines exported to the U.S. for at least 3 years, in return for the U.K. spending more on new medicines

AI Summary: In a twist worthy of a Hollywood trade drama, officials announced that the UK and US have struck a deal to impose zero tariffs on UK‐made medicines destined for the US. As part of the arrangement, the UK must shell out considerably more for drug pricing—a move set to avoid tariffs that could soar as high as 100%—with the agreement effective for at least three years.

#healthcare #pharmaceuticals #drugpricing #governmentpolicy

5 months / go

5 months / bbc


Back to Top / Monday, December 1, 2025, 1:23 pm / permalink 16444 / 6 stories in 5 months /

Medicare premiums set to rise 10% next year, CMS says

Rebecca Pifer / healthcaredive - The Part B premium hike could have been worse, the Trump administration said. Still, it’s likely to pressure the pocketbooks of millions of seniors, and could drive more into Medicare Advantage plans.

AI Summary: CMS has announced that Medicare Part B premiums will jump by 10% next year—a move that will affect millions of enrollees. With these new cost pressures hitting an already strained budget environment, experts warn beneficiaries should brace for a challenging financial landscape moving forward.

#healthcare #publichealth #governmentpolicy

6 months / fiercehealthcare


Back to Top / Saturday, November 22, 2025, 9:22 am / permalink 16211 / 2 stories in 6 months /

CMS issues new telehealth guidance: 4 notes

Giles Bruce / beckershospitalreview - CMS has released updated telehealth guidance following the end of the 43-day government shutdown. Here are four things to know from the November FAQ: 1. CMS will retroactively pay for telehealth claims for services rendered amid the fiscal standoff. 2. Me…

AI Summary: The Centers for Medicare & Medicaid Services has released new telehealth guidance in the wake of the government shutdown. The updated policy clarifies claim submissions and resolves technical issues to better accommodate providers’ needs as they pivot to remote care.

#healthcare #publichealth #governmentpolicy

6 months / fiercehealthcare


Back to Top / Saturday, November 22, 2025, 12:21 am / permalink 16202 / 2 stories in 6 months /

CMS ups hospital outpatient rates 2.6%, expands site-neutral payments in 2026: 14 notes

Alan Condon / beckershospitalreview - CMS on Nov. 21 finalized its Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System rule for 2026, enacting reforms to boost price transparency and expand outpatient access. Fourteen things to know: Hospital outpatien…

AI Summary: CMS has finalized a rule that increases reimbursements to hospital outpatient centers and ambulatory surgical centers by 2.6%, and expands site‐neutral payment policies set for 2026. The move is aimed at aligning provider payments with rising costs amidst evolving care delivery models.

#healthcare #publichealth #governmentpolicy

6 months / fiercehealthcare


Back to Top / Saturday, November 22, 2025, 12:21 am / permalink 16203 / 2 stories in 6 months /

WHO declares end of Indonesia's poliovirus outbreak following yearslong vaccination campaign

medicalxpress - The World Health Organization has declared Indonesia's polio outbreak officially over, following nearly three years of intensive response efforts, officials said Friday.

AI Summary: The World Health Organization has officially declared Indonesia’s poliovirus outbreak over after nearly three years of intensive vaccination campaigns and public health efforts. Officials emphasize that sustained immunisation and surveillance remain essential to preserve this hard‐won success.

#healthcare #publichealth #governmentpolicy #vaccinesafety

6 months / medicalxpress

6 months / go


Back to Top / Saturday, November 22, 2025, 12:21 am / permalink 16201 / 2 stories in 6 months /

Healthcare groups decry CDC messaging change on autism and vaccines

Mackenzie Bean / beckershospitalreview - Healthcare associations are raising concerns after the CDC this week removed messaging from its website stating that vaccines do not cause autism. The agency updated its webpage on vaccines and autism Nov. 19. Previously, the page said research has shown …

AI Summary: Recent modifications to the CDC’s online vaccine safety pages have alarmed healthcare groups, who contend that altered messaging risks bolstering discredited claims linking vaccines and autism. Critics warn that the move may destabilize public confidence in decades of robust, evidence‐based vaccine research.

#healthcare #publichealth #governmentpolicy #cdc #vaccinesafety #autism

5 months / medicalxpress

6 months / fiercehealthcare

6 months / medicalxpress


Back to Top / Thursday, November 20, 2025, 5:23 pm / permalink 16158 / 6 stories in 6 months /

F.D.A. Will Remove Black Box Warnings From Hormone Treatments for Menopause

Roni Caryn Rabin / nytimes - The benefits of hormone replacement have been underappreciated, Dr. Marty Makary, the agency’s commissioner, said on Monday. Critics described evidence for the change as insufficient.

AI Summary: In a bold policy pivot, the FDA will lift long‑standing black box warnings on hormone treatments for menopause. The decision – made without an official advisory committee’s input – updates labeling to better reflect current risk–benefit assessments, leaving critics to wonder if caution has finally given way to progress.

#healthcare #pharmaceuticals #publichealth #governmentpolicy #fda

6 months / medicalxpress


Back to Top / Saturday, November 15, 2025, 10:21 am / permalink 15996 / 3 stories in 6 months /

Historic government shutdown ends, leaving ACA subsidies in limbo

Rebecca Pifer / healthcaredive - The House passed a stopgap funding bill and President Donald Trump signed it late Wednesday, reopening the government without a clear path forward on preserving enhanced subsidies for ACA plans — Democrats’ chief demand.

AI Summary: Following the end of the longest government shutdown in U.S. history, healthcare organizations are calling on lawmakers to secure critical ACA premium tax credits and subsidies, even as government functions resume. Despite reopening, key funding mechanisms remain unresolved—leaving consumers, insurers, and industry experts in a state of cautious uncertainty.

#healthcare #publichealth #governmentpolicy

6 months / fiercehealthcare

6 months / kffhealthnews


Back to Top / Thursday, November 13, 2025, 1:23 pm / permalink 15939 / 11 stories in 6 months /

Richard Pazdur Appointed Director of the FDA’s Drug Center: A New Chapter for Cancer Regulation

oncodaily - Dr. Richard Pazdur, one of the most influential figures in oncology drug regulation, has been appointed Director of the U.S. Food and Drug Administration’s (FDA) Center for Drug Evaluation and […]

AI Summary: The FDA has ushered in a new era in oncology drug oversight by appointing Dr. Richard Pazdur as the director of its Drug Center. The move comes amid agency challenges and staff cuts, promising stabilizing leadership at one of its most influential divisions.

#healthcare #pharmaceuticals #publichealth #governmentpolicy #drugdevelopment #fda

6 months / oncodaily

6 months / oncodaily


Back to Top / Wednesday, November 12, 2025, 6:22 am / permalink 15886 / 8 stories in 6 months /

Canada loses measles elimination status after ongoing outbreaks

go - International health experts say Canada is no longer measles-free because of ongoing outbreaks, as childhood vaccination rates fall and the highly contagious virus spreads across North and South America

AI Summary: Health experts report that Canada has lost its measles elimination status amid large-scale outbreaks and falling vaccination rates. The loss, confirmed by multiple sources, has raised public health alarms and may affect regional disease control efforts.

#healthcare #publichealth #governmentpolicy

6 months / go

6 months / medicalxpress

6 months / livescience

6 months / medicalxpress


Back to Top / Monday, November 10, 2025, 11:22 pm / permalink 15856 / 4 stories in 6 months /

FDA rolls back warning labels on HRT products for menopause, citing misinformation

fiercehealthcare - The action, announced Monday, follows a comprehensive review of scientific literature by an expert panel at the agency in July, as well as a public comment period, officials said. Pharmas are expected to update and reprint their product labeling to remove…

AI Summary: Following a rigorous review of the scientific evidence, federal regulators are scrapping boxed warnings on hormone replacement products used for menopausal symptom relief. The move—aimed at increasing treatment access—casts a skeptical eye on long-held safety fears, inviting both applause and a few sarcastic raised eyebrows in the industry.

#healthcare #pharmaceuticals #publichealth #governmentpolicy

6 months / medicalxpress

6 months / fiercehealthcare


Back to Top / Monday, November 10, 2025, 5:24 pm / permalink 15854 / 5 stories in 6 months /

CMS unveils new Medicaid drug payment model

Max Bayer / endpoints - CMS plans to launch a new drug payment model for state Medicaid programs, the first of potentially multiple pricing models under President Donald Trump's "most favored nation" push that the pharma industry has been closely ...

AI Summary: The Centers for Medicare and Medicaid Services has introduced a novel Medicaid drug payment model that employs a most-favored nation pricing strategy, aiming to rein in healthcare spending. This bold move signals a shift toward competitive pricing that, while promising cost efficiencies, also raises eyebrows over its unorthodox approach.

#healthcare #pharmaceuticals #drugpricing #publichealth #governmentpolicy

6 months / fiercehealthcare


Back to Top / Saturday, November 8, 2025, 12:21 am / permalink 15785 / 3 stories in 6 months /

What Trump’s New Drug Pricing Deal Means for People With Obesity

Rebecca Robbins, Dani Blum and Margot Sanger-Katz / nytimes - The president’s agreement with drug companies involves a range of prices, depending on dose, product and how you’re paying.

AI Summary: In a bold move to tackle the obesity crisis, the Trump administration has brokered agreements with industry giants such as Eli Lilly and Novo Nordisk to slash weight-loss drug prices. The deals, promising reductions as steep as $149 a month, have sparked both applause and debate over the future of drug pricing in America.

#trumpadministration #obesity #healthcare #pharmaceuticals #drugpricing #elililly #novonordisk #weightloss #publichealth #governmentpolicy

6 months / fiercehealthcare


Back to Top / Friday, November 7, 2025, 11:57 pm / permalink 15780 / 6 stories in 6 months /

Back to Top


GOVERNMENTPOLICY Heatmap


90 days, weeks are vertical, left is older; hover for info, click to see that day's coverage.


Warning: Undefined variable $target_date in /home3/thegood9/public_html/website_70aad9ea/tag.php on line 300

StackHealth RSS


You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Public Health, Behavioral Health, FDA, Avian Influenza and look for the RSS link.


NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.